MedTrace Logo

Use of the FreeStyle Navigator Continuous Glucose Monitoring System to Enhance Education and Glycaemic Control

NCT01214824 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2013-07-02

Study results available
· View outcomes & findings →

Summary

To demonstrate that in patients with persistent poorly controlled diabetes, short/intermittent use of continuous glucose monitoring can driver better longer-term glycaemic control and HbA1c.

Conditions

Interventions

DEVICE

FreeStyle Navigator Continuous Glucose Monitoring System

Six x 5 day wears of the continuous glucose monitoring device. Two of the 6 wears will be using a masked device (1 at the start and 1 at the end of the study).

Sponsors & Collaborators

  • Liverpool University Hospitals NHS Foundation Trust

    collaborator OTHER_GOV

  • National Heatlh Service Ayrshire and Arran

    collaborator OTHER_GOV

  • NHS Lothian

    collaborator OTHER_GOV

  • National Health Service, United Kingdom

    collaborator OTHER_GOV

  • Cardiff and Vale University Health Board

    collaborator OTHER_GOV

  • Abbott Diabetes Care

    lead INDUSTRY

Principal Investigators

  • Jiten Vora, MRCP · The Royal Liverpool and Broadgreen University Hospitals NHS Trust

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2012-02-29
Completion
2012-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01214824 on ClinicalTrials.gov